share_log

Jasper Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Soleus Capital Master Fund, L.P.(8.8%),Soleus Capital, LLC(8.8%), etc.

Jasper Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Soleus Capital Master Fund, L.P.(8.8%),Soleus Capital, LLC(8.8%)等

SEC announcement ·  02/02 09:55
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息